Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
María E. Figueroa(Cornell University), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Chao Lü(University of Pennsylvania), Patrick S. Ward(University of Pennsylvania), Jay Patel(Memorial Sloan Kettering Cancer Center), Alan H. Shih(Memorial Sloan Kettering Cancer Center), Yushan Li(Cornell University), Neha Bhagwat(Memorial Sloan Kettering Cancer Center), Aparna Vasanthakumar(University of Chicago), Hugo F. Fernández(Moffitt Cancer Center), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Zhuoxin Sun(Dana-Farber Cancer Institute), Kristy Wolniak(Northwestern University), Justine Peeters(Erasmus MC), Wei Liu(Agios Pharmaceuticals (United States)), Sung Choe(Agios Pharmaceuticals (United States)), Valeria R. Fantin(Agios Pharmaceuticals (United States)), Elisabeth Paietta(Montefiore Medical Center), Bob Löwenberg(Erasmus MC), Jonathan D. Licht(Northwestern University), Lucy A. Godley(University of Chicago), Ruud Delwel(Erasmus MC), Peter J.M. Valk(Erasmus MC), Craig B. Thompson(University of Pennsylvania), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Ari Melnick(Cornell University)
Cited by 2,728Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis